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Three-Year Outcomes of the IMPROVE Trial for Ruptured Abdominal Aortic Aneurysm Janet Powell, MD, IMPROVE Trial Investigators. Imperial College London, London, United Kingdom
Objectives: This study compared mortality and reinterventions between patients randomized to either an endovascular strategy or open repair 3 years previously and evaluated how these outcomes were influenced by preoperative aortoiliac morphology.
Methods: Multicenter randomized controlled trial (ISRCTN 48334791), recruiting 613 patients between September 2009 and July 2013: computed tomography (CT) scans were assessed in a core laboratory. Patients were followed up by trial centers, with deaths reported by national registers and reinterventions taking place at nontrial centers obtained from audit and/or administrative databases. After patient discharge, reinterventions were categorized as arterial, laparotomyrelated, or other and scored for clinical severity by investigator consensus and patient-perceived severity. The influence of preoperative aortoiliac morphology on reinterventions was assessed. Statistical analysis was according to prespecified plans approved by the trial writing committee (Table) .
Results: After 3 years, five patients had been lost to follow-up due to emigration, and 151 of 313 (48%) and 165 of 295 (56%) patients had died in the endovascular strategy and open repair groups, respectively (c 2 P ¼ .058). There was a similar quality-adjusted life-year benefit for the endovascular strategy group at 3 years. In the endovascular strategy group, there were 130 reinterventions in 76 of 316 patients. In the open repair group, there were 113 reinterventions in 68 of 297 patients. Over the 3 years of follow-up, the rate at which reinterventions occurred were similar in the 2 groups (24.0 and 26.8 per 100 person-years in the endovascular strategy and open repair groups, respectively). Between 3 months and 3 years the reintervention rate was low but twice as high in the endovascular strategy group (8.4 vs 4.3 per 100 personyears), although many of these reinterventions were minor (severity score to be presented). From a patient perspective, there were more severe reinterventions (limb amputation, graft infection, secondary ruptures, major redo procedures, and unclosed ostomies) in patients following open repair (19 of 248 vs 7 of 186; c 2 P ¼ .09). There were three secondary ruptures within 3 years of follow-up, all in EVAR patients. The influence of preoperative aortoiliac morphology on reintervention rates also will be reported.
Conclusions: After 3 years, the endovascular strategy emerges as the better care pathway for patients and does not appear to be associated with a greater rate of serious late reinterventions. Future reporting standards for ruptured aneurysm repair should include metrics such as amputation and graft infection (important to patients).
Author Disclosures: I. Investigators: Nothing to disclose; J. T. Powell: Nothing to disclose. Objectives: Fenestrated endografts are customized, patient-specific, endovascular devices with the potential to reduce morbidity and mortality of repair of complex aortic aneurysms. With approval from the United States Food and Drug Administration, our center began performing fenestrated endovascular aneurysm repair through a physician-sponsored investigational device exemption (IDE #G130210), using both physician-modified endografts (PMEG) and company manufactured devices (CMD). Because PMEG and CMD are each associated with specific advantages and disadvantages, we sought to investigate differences in outcomes between PMEG and CMD cases.
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A Matched Cohort Comparison of Outcomes in
Methods: A single-institution retrospective review of all fenestrated endovascular aneurysm repairs was performed. The cohort was analyzed according to device type (PMEG or CMD) after matching cases based on (1) number of target vessels intended for treatment, (2) extent of aneurysm, (3) aneurysm diameter, (4) device configuration, and (5) date of operation. Outcomes of ruptures, common iliac, and arch aneurysms were excluded. Demographics, operative details, perioperative complications, length of stay, and reinterventions were compared. For patients 
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